Skip to main content

Month: May 2020

DPA Group N.V.: Aandeelhouders DPA akkoord met herbenoeming Ron Icke als voorzitter Raad van Commissarissen

Amsterdam, 19 mei 2020 – De aandeelhouders van DPA hebben tijdens de jaarvergadering op 18 mei 2020 ingestemd met de herbenoeming van Ron Icke als lid van de Raad van Commissarissen voor een periode van twee jaar. Ron Icke zal tevens de functie van voorzitter blijven vervullen. Daarnaast hebben de aandeelhouders het remuneratiebeleid van de Raad van Commissarissen en van de Raad van Bestuur goedgekeurd.Het Bestuur heeft met instemming van de Raad van Commissarissen besloten om over het boekjaar 2019 geen dividend uit te keren. Conform het dividendbeleid van DPA zou in een normale situatie voorgesteld zijn om 0,08 euro per aandeel als dividend uit te keren. Gezien de huidige externe omstandigheden is besloten om van dividenduitkering af te zien en het volledige nettoresultaat van 2019 van 7,8 miljoen euro aan de algemene reserves...

Continue reading

Investment Outlook: Restart after sudden halt?

The rug was pulled out from under risk assets during March, as investors realised the severity of COVID-19 and its impact on the global economy. Central banks and governments responded rapidly and aggressively with stimulus packages, but the economic damage left behind by the pandemic will undoubtedly take time to repair. The question that investors are asking themselves is how fast economies can be restarted and revert to some kind of normality. Our forecast is a short but deep recession this year, followed by a robust recovery in 2021.“Although it will probably take several years before the economy returns to its old growth trends, we still expect the rebound to begin during the next few quarters. Continued low interest rates and bond yields, as well as the prospect of several years of recovery-driven economic growth, suggest that higher...

Continue reading

Investment Outlook: Omstart efter tvärnit?

Mattan drogs undan för risktillgångar under mars när investerare insåg allvaret med covid-19 och dess effekter på den globala ekonomin. Centralbanker och regeringar har stöttat snabbt och kraftfullt, men det råder inget tvivel om att de ekonomiska skadorna kommer ta tid att reparera. Frågan som investerare ställer sig är i vilken takt som ekonomierna kan återstartas och återgå till någon slags normalitet. Vår prognos är en kort, men djup, recession i år, som följs av en kraftig återhämtning nästa år.      –    Det kommer förvisso att dröja flera år innan ekonomin är tillbaka till gamla tillväxttrender, men vi räknar ändå med att återtåget inleds under kommande kvartal. Fortsatt låga räntor och utsikter till flera år av återhämtningsdriven tillväxt talar för att högre värderingar kan accepteras framöver. Vi ser i dagsläget eventuella...

Continue reading

Compagnie Financière Tradition: Stock dividend proposed at the Annual General Meeting on May 19, 2020

Stock dividend proposed at the Annual General Meetingon May 19, 2020 The Annual General Meeting of Compagnie Financière Tradition SA to be held on May 19, 2020 at 3.30 pm, at the company’s headquarters, to approve the company and group accounts for the 2019 financial year will vote on the distribution of dividend, in accordance with and subject to the proposal of the Board of Directors, published in the Swiss Official Gazette of Commerce on April 24, 2020.The Board has proposed the dividend consists of a cash payment of a gross amount of CHF 5.00 (“cash dividend”) per bearer share of CFT with a nominal value of CHF 2.50 (“bearer share(s)”) and the distribution of one bearer share for every 50 bearer shares held (“stock dividend”).The reference share price for the stock dividend corresponds to the average of the closing prices of the Compagnie...

Continue reading

Compagnie Financière Tradition: Dividende en actions proposé à l’Assemblée Générale du 19 mai 2020

Dividende en actions proposé à l’Assemblée Générale du 19 mai 2020L’Assemblée générale de Compagnie Financière Tradition SA à tenir ce 19 mai 2020, à 15 heures 30, au siège de la société, pour l’approbation des comptes annuels de la société et des comptes consolidés pour l’exercice 2019, se prononcera sur le paiement du dividende, conformément et sous les réserves de la proposition du Conseil d’administration parue à la Feuille Officielle Suisse du Commerce en date du 24 avril 2020.Le Conseil d’administration a proposé que le dividende soit constitué d’un paiement en espèces d’un montant brut de CHF 5,00 (« dividende en espèces ») par action CFT au porteur d’une valeur nominale de CHF 2,50 (« action(s) au porteur ») et de la distribution d’une action au porteur pour 50 actions au porteur détenues (« dividende en actions »).Le cours de référence...

Continue reading

Compagnie Financière Tradition: Stock dividend proposed at the Annual General Meeting on May 19, 2020

Stock dividend proposed at the Annual General Meeting on May 19, 2020 The Annual General Meeting of Compagnie Financière Tradition SA to be held on May 19, 2020 at 3.30 pm, at the company’s headquarters, to approve the company and group accounts for the 2019 financial year will vote on the distribution of dividend, in accordance with and subject to the proposal of the Board of Directors, published in the Swiss Official Gazette of Commerce on April 24, 2020.The Board has proposed the dividend consists of a cash payment of a gross amount of CHF 5.00 (“cash dividend”) per bearer share of CFT with a nominal value of CHF 2.50 (“bearer share(s)”) and the distribution of one bearer share for every 50 bearer shares held (“stock dividend”).The reference share price for the stock dividend corresponds to the average of the closing prices of the Compagnie...

Continue reading

WISeKey “Foresight” IoT Early Warning System technologies can be used to facilitate the detection of future virus outbreaks

WISeKey “Foresight” IoT Early Warning System technologies can be used to facilitate the detection of future virus outbreaksRegister to Webinar: Securing the IoT health industry during the COVID19 CrisisJune 4th @ 03:00 pm CEThttps://www.wisekey.com/wisekey-webinar/Geneva, Switzerland – May 19, 2020: WISeKey International Holding Ltd. (“WISeKey”) (SIX: WIHN, NASDAQ: WKEY), a leading global cybersecurity and IoT company, announced today that it is partnering with global technology organizations to provide an IoT early warning system that can be used to facilitate early detection of viruses and future outbreaks.WISeKey is teaming with several leading partners (https://www.wisekey.com/partners/)for the development of an IoT Early Warning System (EWS) designed with the objective of saving lives through early detection as one of the main technology...

Continue reading

Addex Therapeutics Establishes Scientific Advisory Board

 World-leading experts will support our strategic decision-making processes as we continue advancing our pipeline of allosteric modulatorsGeneva, Switzerland, May 19, 2020 – Addex Therapeutics Ltd (SIX and Nasdaq: ADXN), a clinical-stage pharmaceutical company pioneering allosteric modulation-based drug discovery and development, announced today that it has established a Scientific Advisory Board (SAB) led by Darryle Schoepp, PhD, as Chairman (see Press Release) and including fellow world-leading neuroscientists and drug discovery & development experts, Prof. Mark F. Bear, PhD, Peter R. Bernstein, PhD, and Prof. Bernard Bettler, PhD. The SAB will provide valuable insight to help steer future application of Addex proprietary allosteric modulation technology platform and unique pipeline in neurological and other diseases.‘‘The...

Continue reading

FDA approves Roche’s Tecentriq as a first-line monotherapy for certain people with metastatic non-small cell lung cancer

Tecentriq’s fourth indication in metastatic non-small cell lung cancer and fifth indication in lung cancer overall in the US Approval based on the Phase III IMpower110 study showing Tecentriq demonstrated a significant overall survival benefit in people with high PD-L1 expression compared with chemotherapyBasel, 19 May 2020 – Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that the US Food and Drug Administration (FDA) has approved Tecentriq® (atezolizumab) as a first-line (initial) treatment for adults with metastatic non-small cell lung cancer (NSCLC) whose tumours have high PD-L1 expression (PD-L1 stained ≥ 50% of tumour cells [TC ≥ 50%] or PD-L1 stained tumour-infiltrating [IC] covering ≥ 10% of the tumour area [IC ≥ 10%]), as determined by an FDA-approved test, with no EGFR or ALK genomic tumour aberrations.Tecentriq monotherapy,...

Continue reading

SIKA PRODUCES SAFETY MASKS FOR EMPLOYEES AND CUSTOMERS

SIKA PRODUCES SAFETY MASKS FOR EMPLOYEES AND CUSTOMERSSika has commenced production of respiratory masks in France. In addition to hand sanitizer, which is being manufactured at over 15 Sika national subsidiaries since March 2020, safety masks are now being produced for employees, customers, and other interested parties. Production capacity stands at around 15,000 masks per day.At the Les Salles du Gardon factory in southern France, Sika has commenced the production of respiratory masks made almost entirely from Sika products. Nearly 50,000 masks have already been produced and orders placed for over 165,000 more. The masks incorporate polyester-based protective layers normally inserted between base and membrane in roof waterproofing as well as silicone-based sealants used for glazing and jointing in construction facilities.Not only do...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.